PHARMACOECONOMIC ASPECTS OF TREATMENT OF CHILDREN'S ATOPIC DERMATITIS
Abstract
The authors have studied 300 cases of atopic dermatitis at children being at the age of 3 — 18. Based on the medical documentation analysis and questioning, they ascertained high cost of the disease both for the family and the state. Structure and amount of costs depended on duration and severity of the disease. On the whole, the authors point out that atopic dermatitis has negative impact upon life quality of the patients and their families, nevertheless there is a need to carry out further pharmacoeconomic researches.
About the Authors
V. V. Derkach
Vladivostok State Medical University; Far-Eastern Branch of Scientific and Research Institute of Clinical Immunology of the Siberian Branch of the Russian Academy of Medical Science; Children's Municipal Clinical Hospital (Vladivostok)
Russian Federation
Russian Federation
E. V. Prosekova
Vladivostok State Medical University; Far-Eastern Branch of Scientific and Research Institute of Clinical Immunology of the Siberian Branch of the Russian Academy of Medical Science; Children's Municipal Clinical Hospital (Vladivostok)
Russian Federation
Russian Federation
G. V. Vinokhodova
Vladivostok State Medical University; Far-Eastern Branch of Scientific and Research Institute of Clinical Immunology of the Siberian Branch of the Russian Academy of Medical Science; Children's Municipal Clinical Hospital (Vladivostok)
Russian Federation
Russian Federation
I. S. Sergienko
Vladivostok State Medical University; Far-Eastern Branch of Scientific and Research Institute of Clinical Immunology of the Siberian Branch of the Russian Academy of Medical Science; Children's Municipal Clinical Hospital (Vladivostok)
Russian Federation
Russian Federation
References
1. Атопический дерматит. Рекомендации для практических врачей. — Российский согласительный документ по атопическому дерматиту. — М., 2002.
2. Атопический дерматит у детей. Диагностика, лечение и профилактика: Научно-практическая программа. — М., 2001.
3. Белоусов Ю.Б. Ольбинская Л.И., Быков А.В.// Клинич. фармакология и терапия. — 1997. — № 6. — С. 83-85.
4. Виноградов А.В.// Фармаптека. — 1994. — № 2. — С. 14-23.
5. Кобельт Ж.// Клинич. фармакол. и терапия. — 1999.-№8.-С. 60-64.
6. Кобельт Ж.// Клинич. фармакол. и терапия. — 1999.-№9.-С. 93-94.
7. Кобина С.А., Семенов В.Ю.//Проблемы стандартизации в здравоохранении. — 1999. — № 1. — С. 39-48.
8. Медников Б.Л.//Хронические обструктивные болезни легких/ Под ред. А.Г. Чучалина. — М.: Медицина, 1998. - С. 501-510.
9. Экология и здоровье детей/ Под ред. М.Я. Студеникина и А.А. Ефимовой. — М.: Медицина, 1998.
10. Bjorksten B., Dumitrascu D., Foucard T. et al.// Eur. Resp. J. - 1997.-No. 10. - Р. 743-749.
11. Correali C.E., Walker C., Murphy L.// Am. Family Physiacian. - 1999. - Vol. 60. - P. 1191-1197.
12. Strachan D., Sibbald B., Weiland S. et al.//Pediatr. Allergy Immunol. - 1997. - NS. - P. 161-176.
13. Walley T., Haycox A.// Br. J. Clin. Pharmacol. - 1997. - Vol. 43, No. 4. - P. 343-348.
Review
For citations:
Derkach V.V., Prosekova E.V., Vinokhodova G.V., Sergienko I.S. PHARMACOECONOMIC ASPECTS OF TREATMENT OF CHILDREN'S ATOPIC DERMATITIS. Pacific Medical Journal. 2004;(3):73-76. (In Russ.)
Views:
288
Email this article 